Social Media Post Implying Continual-G Glutathione Enhancer Protects Against COVID-19 is Discontinued Following NAD Inquiry

For Immediate Release 

Contact: Abby Hills, Director of Communications, BBB National Programs 

301.412.7769 / ahills@bbbnp.org 

 

New York, NY – June 29, 2020 – Following an inquiry by the National Advertising Division (NAD), INID Research Lab, LLC discontinued a social media post that conveyed an implied message that the immunity-boosting capabilities of Continual-G Glutathione Enhancer protect consumers against COVID-19. The challenged social media post showed an image of a woman wearing a face mask with the text, “Strong IMMUNITY Needs Glutathione” and associated text stating “Building your immunity during these times is more important than ever.” 

Through a routine monitoring program, NAD challenged the advertisement by INID Research, noting that the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) have both stated that there are no approved vaccines, drugs, or investigational products currently available to treat or prevent COVID-19. Both the FDA and Federal Trade Commission have issued dozens of warning letters to companies making claims about their products’ ability to treat or prevent COVID-19. Health and safety concerns are a top priority for NAD’s monitoring efforts, with attention currently focused on advertising for COVID-19 treatments. 

NAD appreciated the advertiser’s discontinuance of the social media post in question and its commitment to avoid making any express or implied claims that promote its product’s ability to protect consumers against COVID-19. 

In its advertiser’s statement, INID Research stated that it has “removed any and all imagery found to be suggestive of effects of our product on preventing, treating, or mitigating” COVID-19 and that it has “no intention of inclusion of any sort of claim, express or implied, in any marketing materials associated with its products relative to this serious disease.” 

 

### 

 

About the National Advertising Division: The National Advertising Division (NAD), a division of BBB National Programs, provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and leveling the playing field for business.     

About BBB National Programs: BBB National Programs is where businesses turn to enhance consumer trust and consumers are heard. This independent, non-profit organization enhances trust, innovation, and competition in the marketplace through the development and delivery of cost-effective, third-party self-regulation, dispute resolution, and accountability programs. BBB National Programs’ 10 leading industry self-regulation and dispute resolution programs resolve business issues of national and international importance, and fosters industry best practices in truth-in-advertising, child-directed marketing, data privacy, and dispute resolution. To learn more about industry self-regulation, visit bbbprograms.org.   

Latest Decisions

Decision

NARB Recommends S.C. Johnson Discontinue Unqualified “Non-Toxic” Claim on Windex Vinegar Glass Cleaner

A panel of the National Advertising Review Board (NARB), a division of BBB National Programs, has recommended that S.C. Johnson & Son, Inc. (S.C. Johnson) discontinue the claim “non-toxic” on package labeling for its Windex Vinegar Glass Cleaner. However, the panel determined that a properly qualified non-toxic claim,...
Read more
Decision

Truvani Voluntarily Discontinues Social Media Post and Two Consumer Reviews for Immune Support Following NAD Inquiry into Implied COVID-19 Messages

Following an inquiry by the National Advertising Division (NAD) of BBB National Programs, Nomolotus, LLC d/b/a Truvani discontinued a social media post for its Immune Support dietary supplement (formerly called “Under the Weather”), as well as two customer reviews...
Read more
Decision

NAD Refers IV Drips to FDA and FTC for Claims that IV Hydration Therapy Protects Against COVID-19

The National Advertising Division (NAD), a division of BBB National Programs, has referred advertising claims made by IV Drips, Customized IV Hydration & Wellness (“IV Drips”) for its IV Hydration Therapy to the U.S. Food and Drug Administration (FDA) and Federal Trade Commission (FTC) for...
Read more
Decision

NAD Finds Certain NanoSeptic Self-Cleaning Surface Claims are Supported; Recommends Modification of Others

Following an inquiry by the National Advertising Division (NAD) initiated as part of its routine monitoring program, NAD determined that NanoTouch Materials, LLC substantiated certain express claims for its NanoSeptic surfaces...
Read more